Jacinda Ardern
Associate Minister, Arts, Culture and Heritage
Minister, Child Poverty Reduction
Minister, Ministerial Services
Minister, National Security and Intelligence
Prime Minister
Kia ora koutou katoa. Good afternoon, everybody. We’ve received the 1 p.m.
Ministry of Health update today, and I’ll hand over to the director-general to speak to that in a moment, but first I’d like to give a brief update on the last 24 hours, along with an update on the arrival of the first shipment of the Pfizer vaccine into New Zealand.
Reports from Auckland suggest the transition to alert level 3 has gone reasonably well, with numbers well down on public transport, meaning people are listening to advice and staying home, and I thank everybody for that. There is active management of some congestion around testing sites, and the online portal for people applying for travel exemptions in and out of the region is functioning well. In terms of an update on those numbers, as at 1.30 today, we have received—we had issued business travel documents for 6,861 workers, with requests for exemptions for a further 1,208 workers currently being assessed. The call centre wait time has been an average of 35 seconds, and at that time there had been 52 calls. It would suggest people are predominantly using the online portal, and they are getting very rapid responses. When you consider last time, for example, we had 6,000 exemptions in total, you can see that we are moving through that border regime at a fairly good pace. Coming now to the cases that we are working on, as confirmed this morning, genome sequencing of the three community COVID cases shows they are the UK variant of the virus. This is highly transmissible and a fast-moving strain, one that requires extra care in order to stamp it out, and it is exactly what our approach entails. Also, the genome sequencing also shows no match to anyone who’s been through a New Zealand MIQ facility that we’ve been able to sequence. However, we continue to pursue a range of theories, some of which have been classified as unlikely or highly unlikely, but, regardless, in our view it’s important to leave no stone unturned, particularly when we know how tricky this virus can be and is.
On that note, I’ll hand over to Dr Bloomfield for an update, and then we’ll return with a few comments.